You are here

Nirvana Life Sciences Inc.

Nirvana Life Sciences Inc.
Listing Exchange: 
CSE
Status: 
Suspended
Industry: 
Life Sciences
Symbol: 
NIRV
CSE Index: 
Currency: 

Nirvana Life Sciences Inc. is focused on developing medical products and regimens that address addiction. Nirvana is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency and other health problems.  

You are here

Nirvana Life Sciences Inc. (NIRV)

SEDAR Information

Company Info

Address
Suite 2110, 650 West Georgia Street
Vancouver, BC V6B 4N8
Canada
Phone
(604) 401-8100
Email
Info@nirvanalifescience.com
Website
https://nirvanalifescience.com
Listing date
Thursday, March 17, 2022
Transfer Agent
Computershare Investor Services Inc.

Capitalization

Issued & Outstanding: 
33020139
Reserved for Issuance: 
300000

Bulletins

05/09/2024

2024-0903 - Suspension - Nirvana Life Sciences Inc. (NIRV)

le 5 septembre/September 2024

Effective immediately, Nirvana Life Sciences Inc. is suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules. A cease trade order has been issued by the British Columbia Securities Commission

For more information about Cease Trade Orders, visit the Canadian Securities Administrators Cease Trade Order database at www.securities-administrators.ca.